Literature DB >> 24557433

Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways.

Xiuli Kong1, Xiaohong Chang, Hongyan Cheng, RuiQiong Ma, Xue Ye, Heng Cui.   

Abstract

OBJECTIVES: Human epididymis protein 4 (HE4) is a promising novel biomarker for the detection of epithelial ovarian cancer (EOC). The role of HE4 in EOC tumorigenesis is unclear. This study investigated the cellular and molecular mechanisms of HE4 in ovarian cancer cell proliferation.
METHODS: We generated HE4-overexpressing SKOV3 cells and silenced HE4 gene expression in SKOV3.ip1 cells. We used the cell counting kit 8 assay to evaluate cell proliferation and Western blotting to analyze the expression of proliferation- and apoptosis-associated proteins such as Bax, Bcl-2, and caspase 3.
RESULTS: Overexpression of HE4 in SKOV3, an ovarian carcinoma cell line, inhibited cell proliferation, In contrast, HE4 silencing in SKOV3.ip1 cells promoted cell proliferation; however, conditioned medium containing HE4 and human recombinant HE4 protein had no effect on proliferation in both SKOV3 and SKOV3.ip1 cells. Human epididymis protein 4 inhibited MEK, extracellular signal-regulating kinase 1/2, and AKT phosphorylation but promoted c-Jun N-terminal protein kinase 1/2/3 and c-JUN phosphorylation; however, p38 phosphorylation was impaired in HE4-overexpressing and silenced cells. Human epididymis protein 4 had no effect on epidermal growth factor receptor phosphorylation or on the apoptosis-associated proteins Bax, Bcl-2, and caspase 3.
CONCLUSIONS: Human epididymis protein 4 might play a protective role in the progression of EOC by inhibiting cell proliferation. Antiproliferative activity was mediated by intracellular HE4 and not the secreted protein. Human epididymis protein 4 might inhibit cell proliferation by regulating the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT signal transduction pathways in vitro.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24557433     DOI: 10.1097/IGC.0000000000000078

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.

Authors:  Guihong Wang; Zhenhua Zhang; Yongqiang Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer.

Authors:  Woo Yeon Hwang; Dong Hoon Suh; Kidong Kim; Yong Beom Kim; Jae Hong No
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

3.  miR-302b suppresses cell invasion and metastasis by directly targeting AKT2 in human hepatocellular carcinoma cells.

Authors:  Lumin Wang; Jiayi Yao; Hongfei Sun; Reifang Sun; Su'e Chang; Yang Yang; Tusheng Song; Chen Huang
Journal:  Tumour Biol       Date:  2015-08-08

Review 4.  The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.

Authors:  L-T Jia; Y-C Zhang; J Li; Y Tian; J-F Li
Journal:  Clin Transl Oncol       Date:  2015-07-29       Impact factor: 3.405

5.  MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2.

Authors:  Jiale Zhang; Jian Zhang; Jie Zhang; Wenjin Qiu; Shuo Xu; Qun Yu; Chengke Liu; Yingyi Wang; Ailin Lu; Junxia Zhang; Xiaoming Lu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

6.  Dysregulated function of normal human epidermal keratinocytes in the absence of filaggrin.

Authors:  Ningning Dang; Xiaoli Ma; Xianguang Meng; Liguo An; Shuguang Pang
Journal:  Mol Med Rep       Date:  2016-07-22       Impact factor: 2.952

7.  Prognostic values of HE4 expression in patients with cancer: a meta-analysis.

Authors:  Cong Dai; Yi Zheng; Yuanjie Li; Tian Tian; Meng Wang; Peng Xu; Yujiao Deng; Qian Hao; Ying Wu; Zhen Zhai; Zhijun Dai; Jun Lyu
Journal:  Cancer Manag Res       Date:  2018-10-10       Impact factor: 3.989

8.  Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer.

Authors:  Liancheng Zhu; Huiyu Zhuang; Huimin Wang; Mingzi Tan; Carlton L Schwab; Lu Deng; Jian Gao; Yingying Hao; Xiao Li; Song Gao; Juanjuan Liu; Bei Lin
Journal:  Oncotarget       Date:  2016-01-05

9.  Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.

Authors:  Chen-Hui Luo; Min Zhao; Yu-Xi Tang; Shohreh Shahabi; Kai-Ning Fang; Yan Chen; Yan Tang; Xiao-Yan Chen; Jing Wang; Hong-Hao Zhou
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

Review 10.  Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.

Authors:  Nicole E James; Clinton Chichester; Jennifer R Ribeiro
Journal:  Front Oncol       Date:  2018-04-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.